{"id":"https://openalex.org/A5014397990","orcid":"https://orcid.org/0000-0002-6781-619X","observed_orcids":["https://orcid.org/0000-0002-6781-619X"],"display_name":"Sarah Kim-McOlash","raw_author_names":["Sarah Kim","Sarah Kim-McOlash"],"full_name":"Sarah Kim-McOlash","works_count":16,"cited_by_count":281,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":8,"i10_index":7},"ids":{"openalex":"https://openalex.org/A5014397990","orcid":"https://orcid.org/0000-0002-6781-619X","observed_orcids":["https://orcid.org/0000-0002-6781-619X"]},"affiliations":[{"institution":{"id":"https://openalex.org/I130238516","ror":"https://ror.org/017zqws13","display_name":"University of Minnesota","country_code":"US","type":"education","lineage":["https://openalex.org/I130238516"]},"years":[2022,2021,2020,2019,2017]},{"institution":{"id":"https://openalex.org/I1309104334","ror":"https://ror.org/04hsn8391","display_name":"Fairview Health Services","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1309104334"]},"years":[2020]},{"institution":{"id":"https://openalex.org/I1320320070","ror":"https://ror.org/034xvzb47","display_name":"United States Food and Drug Administration","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},"years":[2025]},{"institution":{"id":"https://openalex.org/I1333606569","ror":"https://ror.org/00yf3tm42","display_name":"Center for Drug Evaluation and Research","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]},"years":[2025]},{"institution":{"id":"https://openalex.org/I2800403580","ror":"https://ror.org/03grvy078","display_name":"University of Minnesota System","country_code":"US","type":"education","lineage":["https://openalex.org/I2800403580"]},"years":[2022,2021,2020]}],"last_known_institutions":[{"id":"https://openalex.org/I1320320070","ror":"https://ror.org/034xvzb47","display_name":"United States Food and Drug Administration","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","ror":"https://ror.org/00yf3tm42","display_name":"Center for Drug Evaluation and Research","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"topics":[{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","count":7,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","count":5,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","count":5,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","count":5,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11027","display_name":"Metabolism and Genetic Disorders","count":4,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","value":0.0001064,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","value":8.39e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","value":4.97e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12604","display_name":"Glycogen Storage Diseases and Myoclonus","value":3.77e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","value":2.92e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.8888999819755554},{"id":"2775832370","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone acetate","score":0.7943000197410583},{"id":"143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","score":0.7379000186920166},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.6909999847412109},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.5873177647590637}],"counts_by_year":[{"year":2017,"works_count":2,"oa_works_count":2,"cited_by_count":2},{"year":2018,"works_count":0,"oa_works_count":0,"cited_by_count":5},{"year":2019,"works_count":2,"oa_works_count":2,"cited_by_count":14},{"year":2020,"works_count":2,"oa_works_count":2,"cited_by_count":27},{"year":2021,"works_count":1,"oa_works_count":1,"cited_by_count":40},{"year":2022,"works_count":1,"oa_works_count":1,"cited_by_count":46},{"year":2023,"works_count":0,"oa_works_count":0,"cited_by_count":26},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":34},{"year":2025,"works_count":8,"oa_works_count":8,"cited_by_count":34},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":53}],"display_name_alternatives":["Sarah Kim","Sarah Kim-McOlash"],"block_key":"s kim-mcolash","works_api_url":"https://api.openalex.org/works?filter=author.id:A5014397990","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5014397990","updated_date":"2026-11-17T13:41:00","created_date":"2017-05-05T00:00:00"}
